A case of Corynebacterium pseudodiphtheriticum nosocomial pneumonia.To the Editor: Corynebacterium Corynebacterium /Co·ry·ne·bac·te·ri·um/ (-bak-ter´e-um) a genus of bacteria including C. ac´nes, a species present in acne lesions, C. diphthe´riae, the etiologic agent of diphtheria, C. pseudodiphtheriticum has seldom been isolated from patients with upper respiratory tract infections and pneumonia. Most reported infections are community acquired and occur in patients with underlying disease and immunosuppression (1). We report a case characterized by hospital-acquired pneumonia in a debilitated patient. Review of the literature indicates that C. pseudodiphtheriticum should be regarded an emerging pathogen. On April 1, 1998, a 68-year-old woman was admitted to the intensive care unit for acute respiratory distress. She had a 14-month history of amyotrophic lateral sclerosis amyotrophic lateral sclerosis (ALS) (ā'mīətrōf`ik, sklĭrō`sĭs) or motor neuron disease, . Three weeks before admission, she had been hospitalized for Staphylococcus aureus pneumonia and had recovered after treatment with amoxicillin and clavulanic acid plus ciprofioxacin. At the time of admission, the patient had a temperature of 38 [degrees] C. Systolic blood pressure Systolic blood pressure Blood pressure when the heart contracts (beats). Mentioned in: Hypertension was 120 mm Hg. Ventilation was spontaneous, with respirations 24 per minute; pulmonary sibilants were noted. Respiratory acidosis was also identified, with a pH of 7.35, SaO2 92%, PaO2 60 mm Hg, and PaCO2 60 mm Hg. Laboratory data included 18,000 leukocytes per ml (90% polymorpho-nuclear cells) and a serum fibrin level of 7 g/L. A chest X-ray showed pneumopathy of the lower segment of the right lung, which was compatible with the diagnosis of inhalation pneumopathy. On day 2 of admission, the patient's temperature was 39 [degrees] C, and she had paresis of the vocal cords. After C. pseudodiphtheriticum infection was diagnosed, treatment with intravenous cloxacillin cloxacillin /clox·a·cil·lin/ (klok?sah-sil´in) a semisynthetic penicillin; used as the sodium salt to treat staphylococcal infections due to penicillinase-positive organisms. (1 g 3 times/day) and amoxicillin plus clavulanic acid (1 g 3 times/day) was started. On day 3 after admission, the patient's breathing worsened, a radiograph showed bilateral pneumopathy, and she was intubated for mechanical ventilation. Two days later, her breathing improved, and a second bronchic aspiration was sterile. The patient eventually died of unrelated complications. Direct microscopy examination of a Gram-stained bronchial aspiration sample showed numerous polymorphonuclear cells and gram-positive bacilli in parallel rows, which did not show pleomorphism pleomorphism /pleo·mor·phism/ (-mor´fizm) the occurrence of various distinct forms by a single organism or within a species.pleomor´phicpleomor´phous ple·o·mor·phism n. 1. . After 48 hours of incubation at 37 [degrees] C, [10.sup.6] colony-forming units/ml of a coryneform coryneform /co·ry·ne·form/ (-form) denoting or resembling organisms of the family Corynebacteriaceae. coryneform denoting or resembling organisms of the family Corynebacteriaceae. See also diphtheroid. bacillus further identified as C. pseudodiphtheriticum grew in pure culture on blood agar gelose (BioMerieux, La Balme les Grottes, France) under a 5% [CO.sub.2] atmosphere and did not produce hemolysis. The test for catalase was positive, and the following biochemical characteristics were obtained by using a commercial identification strip (ApiCoryne, BioMerieux): absence of carbohydrate fermentation, urea hydrolysis, and nitrate reduction compatible with C. pseudodiphtheriticum. Minimum inhibitory concentrations (disk diffusion method) were 2 mg/L for amoxicillin, 2 mg/L for cefalotin, 0.09 mg/L for doxycycline, 0.03 mg/L for gentamicin, [is less than] 4 mg/L for vancomycin, 16 mg/L for erythromycin, and 20 mg/L for trimethoprim-sulfamethoxazole. Identification was confirmed by analysis of the cell-wall fatty acid profile by the Sherlock system, by the trypticase soy broth agar database 3.9 (MIDI Inc., Newark, DE), and by 16S rRNA sequence analysis under previously described conditions (2). The 16S rRNA gene sequence was compared with all eubacterial 16S rRNA sequences available in the GenBank database by using the multisequence comparison Advanced Blast NCBI. The sequence had a 99% similarity to that of C. pseudodiphtheriticum (1039/1047 base pairs). Eighty-nine cases of infection possibly caused by C. pseudodiphtheriticum have been identified in the last 57 years. Of these, 57 (62.9%) were upper respiratory infections, which included rhinosinusitis, tracheitis tracheitis Inflammation and infection of the trachea. Inhaled irritants can injure the tracheal lining and increase the chance of infection (bacterial or viral). Acute infections, usually bacterial, produce fever, fatigue, and swelling of the tracheal lining but generally do , tracheobronchitis, and bronchitis; 19 (21.3%) were pneumonia (3-7). Ten (11.2%) cases of endocarditis were reported (8); there was also one case each of urinary tract malakoplakia after renal transplantation (9), lung abcess (10), diskitis (11), and lymphadenitis Lymphadenitis Definition Lymphadenitis is the inflammation of a lymph node. It is often a complication of a bacterial infection of a wound, although it can also be caused by viruses or other disease agents. (12). Unlike C. diphtheriae, C. pseudodiphtheriticum is a commensal commensal /com·men·sal/ (kom-men´sil) 1. living on or within another organism, and deriving benefit without harming or benefiting the host. 2. a parasite that causes no harm to the host. bacterium that does not produce toxins and needs predisposing factors to become a pathogen causing pneumonia. Of patients with hospital-acquired C. pseudodiphtheriticum upper respiratory tract infections and pneumonia (7 of 26 upper respiratory tract infections and 2 of 14 cases of pneumonia reported in the early 1990s), all had underlying pathologic features. Predisposing factors were as follows: 33.7% had lung and tracheobronchial tracheobronchial /tra·cheo·bron·chi·al/ (-brong´ke-al) pertaining to the trachea and bronchi. tra·che·o·bron·chi·al adj. Of or relating to the trachea and the bronchi. diseases, including chronic obstructive pulmonary disease chronic obstructive pulmonary disease n. Abbr. COPD A chronic lung disease, such as asthma or emphysema, in which breathing becomes slowed or forced. , angina (5), chronic emphysema, asthma, and bronchitis (6); 32.5% had congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. (5). Of those with immunodepression im·mu·no·de·pres·sion n. See immunosuppression. immunodepression an absence or deficient supply of the components of either humoral or cellular immunity, or both. See also agammaglobulinemia, hypogammaglobulinemia, immunodeficiency. , 5% had AIDS, 7.2% had undergone chemotherapy or prolonged steroid use; and 18.2% had other pathologic features, disseminated intravascular coagulation disseminated intravascular coagulation n. Abbr. DIC A hemorrhagic disorder that occurs following the uncontrolled activation of clotting factors and fibrinolytic enzymes throughout small blood vessels, resulting in tissue necrosis and (6), chronic renal failure chronic renal failure Chronic kidney failure Nephrology A slow decline in renal function, which may be 2º to chronic HTN, DM, CHF, SLE, or sickle cell anemia and, if extreme, leads to ESRD, mandating kidney dialysis; an abrupt decline in renal function may be , diabetes mellitus (5), and connective tissue disease connective tissue disease Autoimmune disease, collagen-vascular disease Any of the diseases affecting connective tissues, with an autoimmune component, and immunologic/inflammatory defects Clinical Arthritis, connective tissue defects, endocarditis, myositis, (5,6). The first source of pneumonia is usually inhalation, as was the case for our patient, who had paresis of the vocal cords. She was not immunosuppressed but was debilitated by amyotrophic lateral sclerosis. The second factor is often an endotracheal intubation, as reported in a previously healthy 29-year-old trauma victim who contracted pneumonia due to C. pseudodiphtheriticum after 7 days of intubation intubation /in·tu·ba·tion/ (in?too-ba´shun) the insertion of a tube into a body canal or hollow organ, as into the trachea. endotracheal intubation (7). An increase in cases reported from 1932 to 1998 indicates the emergence of infections due to C. pseudodiphtheriticum. Thirty-four cases were reported from 1932 to 1989 (57 years), and 55 cases were reported from 1990 to 1998 (8 years). Reasons for the emergence of C. pseudodiphtheriticum infections may include confusion between C. diphtheriae and C. pseudodiphtheriticum infections. For example, two cases of C. pseudodiphtheriticum exudative exudative of or pertaining to a process of exudation. exudative diathesis a disease of young pigs and chickens caused by a nutritional deficiency of vitamin E. Characterized by severe edema of the subcutaneous tissues. upper respiratory tract infections with a pseudomembrane pseudomembrane /pseu·do·mem·brane/ (-mem´bran) false membrane.pseudomem´branous pseu·do·mem·brane n. See false membrane. were first diagnosed as respiratory diphtheria. In the first case, C. pseudodiphtheriticum was isolated from a 32-year-old Uzbek man who had a severe sore throat and dysphagia lasting 2 days (3). In a second case, a 4-year-old girl had exudative pharyngitis with a pseudomembrane, which was possibly caused by C. pseudodiphtheriticum (4). The availability of commercial strips for the identification of C. pseudodiphtheriticum and 16S rRNA sequencing eliminates such confusion. References (1.) Brown AE. Other Corynebacteria and Rhodococcus. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone; 1995. p. 1874. (2.) Weisburg WC, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991;173:697-703. (3.) Santos MR, Ghandi S, Vogler M, Hanna BA, Holzman RS. Suspected diphtheria in a Uzbek national; isolation of C. pseudodiphtheriticum resulted in a false positive presumptive diagnosis. Clin Infect Dis 1996;22:735. (4.) Izurieta HS, Strebel PM, Youngblood T, Hollis DG, Popovic T. Exudative pharyngitidis possibly due to C. pseudodiphtheriticum, a new challenge in the differential diagnosis of diphtheria. Emerg Infect Dis 1997;3:65-8. (5.) Manzella JP, Kellog JA, Parsey KS. Corynebacterium pseudodiphtheriticum: a respiratory tract pathogen in adults. Clin Infect Dis 1995;20:37-40. (6.) Ahmed K, Kawakami K. Corynebacterium pseudodiphtheriticum: a respiratory tract pathogen. Clin Infect Dis 1995;20:41-6. (7.) Miller RA, Rompalo A, Coyle MB. Corynebacterium pseudodiphtheriticum pneumonia in an immunologically intact host. Diagn Microbiol Infect Dis 1986;4:165-71. (8.) Wilson ME, Shapiro DS. Native valve endocarditis due to Corynebacterium pseudodiphtheriticum. Clin Infect Dis 1992;15:1059-60. (9.) Nathan AW, Turner DR, Aubrey C, Cameron JS, Williams DJ, Ogg CS, et al. Corynebacterium hofmannii infection after renal transplantation. Clin Nephrol 1982;17:315-8. (10.) Andavolu RH, Venkita J, Lue Y, McLean T. Lung abscess involving Corynebacterium pseudodiphtheriticum in a patient with AIDS-related complex. New York State Journal of Medicine 1986;86:594-6. (11.) Wright ED, Richards AJ, Edje AJ. Discitis caused by Corynebacterium pseudodiphtheriticum following ear, nose and throat surgery. Br J Rheumatol 1995;34:585-6. (12.) LaRocco M, Robinson C, Robinson A. Corynebacterium pseudodiphtheriticum associated with suppurative suppurative pertaining to or emanating from suppuration; pus in e.g. suppurative arthritis, bronchopneumonia. lymphadenitis. European Journal of Clinical Microbiology 1987;6:79. Cecile Martaresche, Pierre-Edouard Fournier, Veronique Jacomo, Marc Gainnier, Alain Boussuge, and Michel Drancourt Hopital Salvator, Assistance Publique-Hopitaux de Marseille, Marseille, France |
|
||||||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion